These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15630073)

  • 1. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.
    Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K
    Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
    Heinz A; Siessmeier T; Wrase J; Buchholz HG; Gründer G; Kumakura Y; Cumming P; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
    Am J Psychiatry; 2005 Aug; 162(8):1515-20. PubMed ID: 16055774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving.
    Heinz A; Siessmeier T; Wrase J; Hermann D; Klein S; Grüsser SM; Flor H; Braus DF; Buchholz HG; Gründer G; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
    Am J Psychiatry; 2004 Oct; 161(10):1783-9. PubMed ID: 15465974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
    Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME
    Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.
    Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ
    Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.
    Spreckelmeyer KN; Paulzen M; Raptis M; Baltus T; Schaffrath S; Van Waesberghe J; Zalewski MM; Rösch F; Vernaleken I; Schäfer WM; Gründer G
    Biol Psychiatry; 2011 Oct; 70(8):770-776. PubMed ID: 21802658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
    Fehr C; Yakushev I; Hohmann N; Buchholz HG; Landvogt C; Deckers H; Eberhardt A; Kläger M; Smolka MN; Scheurich A; Dielentheis T; Schmidt LG; Rösch F; Bartenstein P; Gründer G; Schreckenberger M
    Am J Psychiatry; 2008 Apr; 165(4):507-14. PubMed ID: 18316420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.
    Leggio L; Ferrulli A; Cardone S; Miceli A; Kenna GA; Gasbarrini G; Swift RM; Addolorato G
    Alcohol; 2008 Aug; 42(5):375-81. PubMed ID: 18486430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.
    Anton RF; Moak DH; Latham PK
    Arch Gen Psychiatry; 1996 Mar; 53(3):225-31. PubMed ID: 8611059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.
    Guardia J; Catafau AM; Batlle F; Martín JC; Segura L; Gonzalvo B; Prat G; Carrió I; Casas M
    Am J Psychiatry; 2000 Jan; 157(1):127-9. PubMed ID: 10618027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant mesolimbic dopamine-opiate interaction in obesity.
    Tuominen L; Tuulari J; Karlsson H; Hirvonen J; Helin S; Salminen P; Parkkola R; Hietala J; Nuutila P; Nummenmaa L
    Neuroimage; 2015 Nov; 122():80-6. PubMed ID: 26260431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.
    Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
    Alcohol; 2012 Sep; 46(6):511-7. PubMed ID: 22717196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.
    de Laat B; Goldberg A; Shi J; Tetrault JM; Nabulsi N; Zheng MQ; Najafzadeh S; Gao H; Kapinos M; Ropchan J; O'Malley SS; Huang Y; Morris ED; Krishnan-Sarin S
    Biol Psychiatry; 2019 Dec; 86(11):864-871. PubMed ID: 31399255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.